CellaVision AB
STO:CEVI

Watchlist Manager
CellaVision AB Logo
CellaVision AB
STO:CEVI
Watchlist
Price: 235.5 SEK -1.46%
Market Cap: 5.6B SEK
Have any thoughts about
CellaVision AB?
Write Note

CellaVision AB
Cost of Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

CellaVision AB
Cost of Revenue Peer Comparison

Comparables:
EKTA B
S
SUS
GETI B
ARJO B
S
STIL

Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors

Company Cost of Revenue CAGR 3Y CAGR 5Y CAGR 10Y
CellaVision AB
STO:CEVI
Cost of Revenue
-kr242.4m
CAGR 3-Years
-15%
CAGR 5-Years
-19%
CAGR 10-Years
-12%
Elekta AB (publ)
STO:EKTA B
Cost of Revenue
-kr11.3B
CAGR 3-Years
-12%
CAGR 5-Years
-8%
CAGR 10-Years
N/A
S
Surgical Science Sweden AB
STO:SUS
Cost of Revenue
-kr264m
CAGR 3-Years
-130%
CAGR 5-Years
-73%
CAGR 10-Years
N/A
Getinge AB
STO:GETI B
Cost of Revenue
-kr17.3B
CAGR 3-Years
-5%
CAGR 5-Years
-6%
CAGR 10-Years
N/A
Arjo AB (publ)
STO:ARJO B
Cost of Revenue
-kr6.2B
CAGR 3-Years
-8%
CAGR 5-Years
-7%
CAGR 10-Years
N/A
S
Stille AB
STO:STIL
Cost of Revenue
-kr223.6m
CAGR 3-Years
-38%
CAGR 5-Years
-22%
CAGR 10-Years
-15%

See Also

What is CellaVision AB's Cost of Revenue?
Cost of Revenue
-242.4m SEK

Based on the financial report for Jun 30, 2024, CellaVision AB's Cost of Revenue amounts to -242.4m SEK.

What is CellaVision AB's Cost of Revenue growth rate?
Cost of Revenue CAGR 10Y
-12%

Over the last year, the Cost of Revenue growth was -29%. The average annual Cost of Revenue growth rates for CellaVision AB have been -15% over the past three years , -19% over the past five years , and -12% over the past ten years .

Back to Top